Literature DB >> 9130592

Analysis of expression and promoter function of the human inducible nitric oxide synthase gene in DLD-1 cells and monkey hepatocytes.

V E Laubach1, C X Zhang, S W Russell, W J Murphy, P A Sherman.   

Abstract

Upon cytokine induction, inducible nitric oxide synthase (iNOS) mRNA and enzyme activity in DLD-1 cells reached maximal levels at 6 and 8 h, respectively. A 3.7 kb 5'-flanking region of the human iNOS gene was used to prepare luciferase reporter constructs. Upon transfection of these constructs into DLD-1 cells and primary monkey hepatocytes, significant promoter activity was detected in the absence of cytokines, and this activity decreased with successive truncations of the human iNOS promoter. No increase in luciferase activity was observed after cytokine treatment, in spite of the fact that nuclear run-on analysis indicated that iNOS induction in DLD-1 cells was due, in part, to an increase in transcription rate. These results suggest that 3.7 kb of 5'-flanking DNA do not contain all of the elements required for transcriptional induction of the human iNOS gene. This differs from the mouse iNOS gene for which 1.7 kb of 5'-flanking DNA contain most or all of the elements that control iNOS expression in mouse macrophages. Thus, important cell- and species-specific mechanisms may exist for the control of iNOS expression.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9130592     DOI: 10.1016/s0167-4781(96)06909-6

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  4 in total

1.  Identification of hamster inducible nitric oxide synthase (iNOS) promoter sequences that influence basal and inducible iNOS expression.

Authors:  Omar A Saldarriaga; Bruno L Travi; Goutam Ghosh Choudhury; Peter C Melby
Journal:  J Leukoc Biol       Date:  2012-04-18       Impact factor: 4.962

2.  Gemfibrozil, a lipid-lowering drug, inhibits the induction of nitric-oxide synthase in human astrocytes.

Authors:  Kalipada Pahan; Malabendu Jana; Xiaojuan Liu; Bradley S Taylor; Charles Wood; Susan M Fischer
Journal:  J Biol Chem       Date:  2002-09-18       Impact factor: 5.157

3.  Malaria severity and human nitric oxide synthase type 2 (NOS2) promoter haplotypes.

Authors:  Marc C Levesque; Maurine R Hobbs; Charles W O'Loughlin; Jennifer A Chancellor; Youwei Chen; Ariana N Tkachuk; Jennifer Booth; Kistie B Patch; Sallie Allgood; Ann R Pole; Carolyn A Fernandez; Esther D Mwaikambo; Theonest K Mutabingwa; Michal Fried; Bess Sorensen; Patrick E Duffy; Donald L Granger; Nicholas M Anstey; J Brice Weinberg
Journal:  Hum Genet       Date:  2009-10-27       Impact factor: 4.132

4.  Identification of conserved domains in the promoter regions of nitric oxide synthase 2: implications for the species-specific transcription and evolutionary differences.

Authors:  Daniel Rico; Juan M Vaquerizas; Hernán Dopazo; Lisardo Boscá
Journal:  BMC Genomics       Date:  2007-08-08       Impact factor: 3.969

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.